Menu

Experience

Darren DeStefano

    • Thayer Ventures Acquisition Corp. Completes Merger With Inspirato 


    • Allbirds – $348.3 Million IPO 


    • Meredith Agrees to Sell National Media Group to IAC’s Dotdash 


    • BigCommerce Holdings – $345 Million Convertible Senior Notes Offering 


    • Acumen Pharmaceuticals – $160 Million IPO 


    • Meredith Agrees to Sell TV Broadcast Group to Gray Television for $2.8 Billion 


    • Meredith Closes $710 Million of Debt Financings, Redeems Series A Preferred Stock 


    • 908 Devices – $150 Million IPO 


    • Taysha Gene Therapies – $181 Million IPO 


    • Vital Farms – $235.4 Million IPO 


    • Avidity Biosciences - $289 Million IPO 


    • Fangdd $78 Million – IPO 


    • Innate Pharma - $79 Million IPO 


    • Precision BioSciences $145 Million IPO 


    • PhaseBio Pharmaceuticals – $46 Million IPO 


    • Endava – $146 Million IPO 


    • Verrica Pharmaceuticals – $86 Million IPO 


    • Autolus – $173 Million IPO 


    • Cardlytics – $76 Million IPO 


    • BroadSoft Sells to Cisco for $1.9 Billion 


    • Lightstone Ventures Closes $50 Million Singapore Focused Fund; Launches Lightstone Singapore 


    • AveXis – $95 Million IPO 


    • Catabasis Completes $69 Million IPO 


    • Vascular Biogenics Prices IPO 


    • Minerva Neurosciences $32.7 Million IPO 


    • 2U $119 Million Initial Public Offering 


    • Cooley Advises Everyday Health on $100 Million IPO 


    • Amedica Initial Public Offering 


    • Cara Therapeutics $55 Million Initial Public Offering 


    • First US IPO of 2014 for GlycoMimetics